| A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis C Labbaye, I Spinello, MT Quaranta, E Pelosi, L Pasquini, E Petrucci, ... Nature Cell Biology 10 (7), 788-801, 2008 | 272 | 2008 |
| Circulating haemopoietic and endothelial progenitor cells are decreased in COPD P Palange, U Testa, A Huertas, L Calabro, R Antonucci, E Petrucci, ... European Respiratory Journal 27 (3), 529-541, 2006 | 266 | 2006 |
| Ovarian cancers: genetic abnormalities, tumor heterogeneity and progression, clonal evolution and cancer stem cells U Testa, E Petrucci, L Pasquini, G Castelli, E Pelosi Medicines 5 (1), 16, 2018 | 207 | 2018 |
| The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor R Riccioni, ML Dupuis, M Bernabei, E Petrucci, L Pasquini, G Mariani, ... Blood Cells, Molecules, and Diseases 45 (1), 86-92, 2010 | 191 | 2010 |
| Exosome-mediated transfer of miR-222 is sufficient to increase tumor malignancy in melanoma F Felicetti, A De Feo, C Coscia, R Puglisi, F Pedini, L Pasquini, ... Journal of translational medicine 14, 1-15, 2016 | 174 | 2016 |
| TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL R Riccioni, L Pasquini, G Mariani, E Saulle, A Rossini, D Diverio, E Pelosi, ... Haematologica 90 (5), 612-624, 2005 | 155 | 2005 |
| Acidic microenvironment plays a key role in human melanoma progression through a sustained exosome mediated transfer of clinically relevant metastatic molecules Z Boussadia, J Lamberti, F Mattei, E Pizzi, R Puglisi, C Zanetti, L Pasquini, ... Journal of Experimental & Clinical Cancer Research 37, 1-15, 2018 | 130 | 2018 |
| Proteasome inhibitors sensitize ovarian cancer cells to TRAIL induced apoptosis E Saulle, A Petronelli, L Pasquini, E Petrucci, G Mariani, M Biffoni, ... Apoptosis 12, 635-655, 2007 | 81 | 2007 |
| Discovery of a new family of bis-8-hydroxyquinoline substituted benzylamines with pro-apoptotic activity in cancer cells: Synthesis, structure–activity relationship, and action … V Moret, Y Laras, T Cresteil, G Aubert, DQ Ping, C Di, ... European journal of medicinal chemistry 44 (2), 558-567, 2009 | 69 | 2009 |
| A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells E Petrucci, L Pasquini, A Petronelli, E Saulle, G Mariani, R Riccioni, ... Gynecologic oncology 105 (2), 481-492, 2007 | 61 | 2007 |
| Impaired myelopoiesis in mice devoid of interferon regulatory factor 1 U Testa, E Stellacci, E Pelosi, P Sestili, M Venditti, R Orsatti, A Fragale, ... Leukemia 18 (11), 1864-1871, 2004 | 61 | 2004 |
| MicroRNA-146a and AMD3100, two ways to control CXCR4 expression in acute myeloid leukemias I Spinello, MT Quaranta, R Riccioni, V Riti, L Pasquini, A Boe, E Pelosi, ... Blood cancer journal 1 (6), e26-e26, 2011 | 57 | 2011 |
| High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitro NI Noguera, E Pelosi, DF Angelini, ML Piredda, G Guerrera, E Piras, ... Oncotarget 8 (20), 32550, 2017 | 48 | 2017 |
| Salinomycin potentiates the cytotoxic effects of TRAIL on glioblastoma cell lines A Calzolari, E Saulle, ML De Angelis, L Pasquini, A Boe, F Pelacchi, ... PloS one 9 (4), e94438, 2014 | 47 | 2014 |
| A small molecule SMAC mimic LBW242 potentiates TRAIL-and anticancer drug-mediated cell death of ovarian cancer cells E Petrucci, L Pasquini, M Bernabei, E Saulle, M Biffoni, F Accarpio, ... PloS one 7 (4), e35073, 2012 | 47 | 2012 |
| Immunophenotypic features of acute myeloid leukemias overexpressing the interleukin 3 receptor alpha chain R Riccioni, A Rossini, L Calabrò, D Diverio, L Pasquini, F Lococo, ... Leukemia & lymphoma 45 (8), 1511-1517, 2004 | 42 | 2004 |
| The small-molecule compound AC-73 targeting CD147 inhibits leukemic cell proliferation, induces autophagy and increases the chemotherapeutic sensitivity of acute myeloid … I Spinello, E Saulle, MT Quaranta, L Pasquini, E Pelosi, G Castelli, ... Haematologica 104 (5), 973, 2019 | 39 | 2019 |
| SCD5‐induced oleic acid production reduces melanoma malignancy by intracellular retention of SPARC and cathepsin B M Bellenghi, R Puglisi, F Pedini, A De Feo, F Felicetti, L Bottero, ... The Journal of Pathology 236 (3), 315-325, 2015 | 39 | 2015 |
| High sensitivity of ovarian cancer cells to the synthetic triterpenoid CDDO-Imidazolide A Petronelli, E Saulle, L Pasquini, E Petrucci, G Mariani, M Biffoni, ... Cancer letters 282 (2), 214-228, 2009 | 39 | 2009 |
| PLZF-mediated control on c-kit expression in CD34+ cells and early erythropoiesis I Spinello, MT Quaranta, L Pasquini, E Pelosi, E Petrucci, A Pagliuca, ... Oncogene 28 (23), 2276-2288, 2009 | 33 | 2009 |
ugo testaIstituto superiore di sanitaEmail verificata su iss.it
